Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Aspirin therapy in aspirin-exacerbated respiratory disease: a risk-benefit analysis for the practicing allergist.

Aspirin therapy in aspirin-exacerbated respiratory disease: a risk-benefit analysis for the practicing allergist. Allergy Asthma Proc. 2011 Sep-Oct; 32(5):335-40.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.